N
OMED

Nuveen’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Nuveen’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-30,820
Closed -$695 – 1574
2015
Q4 		$695 Buy
30,820
+923
+3% +$18.9K ﹤0.01% 1189
2015
Q3 		$496 Sell
29,897
-34,281
-53% -$687K ﹤0.01% 1322
2015
Q2 		$1.44K Buy
64,178
+42,100
+191% +$1.04M 0.01% 983
2015
Q1 		$569K Buy
+22,078
New +$560K ﹤0.01% 1324

Other funds holding OMED

ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nuveen's OMED Position: Q1 2016 in Review

Nuveen sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q1 2016, closing a stake of 30,820 shares — an estimated $695 sold.

Nuveen first reported a position in OMED in Q1 2015 and held it in 4 quarters. The position peaked at $569K in Q1 2015. 83 funds tracked by Wall St. Rank hold OMED as of Q1 2016.

  • Nuveen reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Nuveen sold 30,820 OncoMed Pharmaceuticals, Inc. shares in Q1 2016, an estimated $695.
  • Nuveen first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2015 and held it in 4 quarters.
  • Nuveen's OncoMed Pharmaceuticals, Inc. position peaked at $569K in Q1 2015.
  • 83 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q1 2016.

Based on Nuveen's 13F filing for Q1 2016, filed 13 May 2016.